Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

23.78 -0.09 (-0.38%)
Streaming Delayed Price Updated: 11:15 AM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
The Smartest Dividend Stocks to Buy With $10,000 Right Now
Thanks to some misguided short-term setbacks, investors can scoop up a trio of dividend-paying bargains here. 
Via The Motley Fool
Topics Earnings World Trade
Michael McTague: How can anyone afford breakthrough medicines?
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national spending on personal health care has 
Via Equities.com
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance. 
Via Benzinga
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via Investor Brand Network
Topics Government
Earnings Outlook For Pfizer
 
Via Benzinga
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
EQNX::TICKER_START (NASDAQ:SNGX),(NYSE:PFE),(NYSE:MRK),(NYSE:BMY),(NASDAQ:INSM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Government
How To Earn $500 A Month From Pfizer Stock Ahead Of Q2 Earnings
Pfizer offers a semi-annual dividend amount of 43 cents per share. Here's how investors can pocket a regular $500 monthly. 
Via Benzinga
This Biotech Stock Could Soar on Upcoming Clinical Data
This weight loss drugmaker may be significantly undervalued right now. 
Via The Motley Fool
3 Top Dividend Stocks to Buy in August
These stocks are great ways for investors to generate passive income. 
Via The Motley Fool
Pfizer's Ascent Signals Broader Health Sector Resilience Amidst Innovation Wave
In a notable shift, shares of Pfizer (NYSE: PFE) have recently edged higher, reflecting a burgeoning strength within the broader health sector. This uptick signals a renewed investor confidence in the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
From Apothecary to Global Powerhouse: The Enduring Legacy of Pfizer
Pfizer (NYSE: PFE), a name synonymous with pharmaceutical innovation and global health, stands as a testament to over 170 years of scientific endeavor and strategic evolution. What began as a modest... 
Via MarketMinute
Topics Economy
Pfizer (PFE) Reports Earnings Tomorrow: What To Expect
Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
The 3 Things That Matter for Pfizer Now
The sell-off of this pharmaceutical giant might be overdone. 
Via The Motley Fool
3 High-Yielding Dividend Stocks That Are Trading Near Their 52-Week Lows
If you are looking for dividend stocks, a good place to start is with unloved stocks like these, with yields of up to 6.4%. 
Via The Motley Fool
Topics Intellectual Property
When You Look Back in a Few Years, You'll Wish You Had Bought This Unstoppable Artificial Intelligence (AI) Stock
Microsoft just became the second company in the world to amass $4 trillion in market capitalization, thanks to its AI businesses. 
Via The Motley Fool
Topics Artificial Intelligence
3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double
These pharmaceutical giants are well worth a second look. 
Via The Motley Fool
Moderna's Key Patent Win Overshadowed By Gloomy Outlook
Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of its global workforce. 
Via Benzinga
Topics Intellectual Property
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
President Donald Trump has issued a 60-day ultimatum to 17 major pharmaceutical companies, demanding that they lower drug prices in the U.S. or face severe consequences. 
Via Benzinga
Topics Government
AtrendLtd Launches "Investing in Medical Innovation" Initiative to Accelerate Healthcare Transformation
August 1, 2025 -- Global investment firm AtrendLtd unveils new strategy focusing on five high-growth healthcare segments, aiming to support medical technology breakthroughs and generate sustainable... 
Via 24-7 Press Release
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says
Pfizer presents a good buying opportunity, but not because of potential earnings. 
Via The Motley Fool
Topics Supply Chain
Where Will Pfizer (PFE) Be in 5 Years?
The big drugmaker should be even bigger over the next five years despite facing a patent cliff. 
Via The Motley Fool
Topics Intellectual Property
3 Cash-Producing Stocks We Keep Off Our Radar
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
The Smartest Dividend Stocks to Buy With $1,000 Right Now
You'll often find the fattest dividend yields among stocks that have tumbled for some reason. 
Via The Motley Fool
Topics Intellectual Property
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Pfizer Stock Is A Value Play Ahead Of Earnings - Investors Can Short PFE Puts For Income
Pfizer, Inc. stock still looks cheap ahead of its upcoming Aug. 5 Q2 earnings release. Moreover, investors can make extra income by selling out-of-the-money (OTM) put options. 
Via Talk Markets
Novo Nordisk Shares Plunge Amid Leadership Shakeup (NYSE:NVO)
In a surprising turn of events, shares of pharmaceutical giant Novo Nordisk (NYSE:NVO) fell sharply following the company’s announcement of a significant leadership restructuring. The abrupt changes at... 
Via MarketMinute
Topics ETFs Economy
Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Costs: Report
The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug prices and restricted... 
Via Benzinga
Topics Government
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), describing the system as fundamentally broken... 
Via Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
These big pharma stocks arguably aren't receiving the respect they deserve. 
Via The Motley Fool
Topics Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.